Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Expert Opinion on Pharmacotherapy
|
October 5, 2001
Options for the pharmacotherapy of toxoplasmosis during pregnancy
F Peyron, M Wallon
The Journal of Biological Chemistry
|
March 14, 1997
The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components
U M Wallon, C M Overall
Journal Francais D'Ophtalmologie
|
December 6, 2020
Do we still need a Goldmann-Witmer coefficient for the diagnosis of ocular toxoplasmosis?
T Mathis, M Wallon, L Kodjikian
The New England Journal of Medicine
|
April 11, 1996
Long-term follow-up of patients with congenital ocular toxoplasmosis
F Peyron, M Wallon, C Bernardoux
Molecular and Cellular Biochemistry
|
May 10, 1995
Regulation of ornithine decarboxylase during cell growth. Changes in the stability and translatability of the mRNA, and in the turnover of the protein
U M Wallon, L Persson, O Heby
FEBS Letters
|
July 30, 1990
Superinduction of ornithine decarboxylase (ODC) by actinomycin D is due to stimulation of ODC mRNA translation
U M Wallon, L Persson, O Heby
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Treatments for toxoplasmosis in pregnancy
F Peyron, M Wallon, C Liou, et al.
Lancet (London, England)
|
August 20, 1994
Toxoplasmosis in pregnancy
M Wallon, F Gandilhon, F Peyron, et al.
BMJ (Clinical Research Ed.)
|
June 4, 1999
Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy
M Wallon, C Liou, P Garner, et al.
The Journal of Biological Chemistry
|
May 12, 1995
Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen
B Steffensen, U M Wallon, C M Overall
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Expert Opinion on Pharmacotherapy
|
October 5, 2001
Options for the pharmacotherapy of toxoplasmosis during pregnancy
F Peyron, M Wallon
The Journal of Biological Chemistry
|
March 14, 1997
The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components
U M Wallon, C M Overall
Journal Francais D'Ophtalmologie
|
December 6, 2020
Do we still need a Goldmann-Witmer coefficient for the diagnosis of ocular toxoplasmosis?
T Mathis, M Wallon, L Kodjikian
The New England Journal of Medicine
|
April 11, 1996
Long-term follow-up of patients with congenital ocular toxoplasmosis
F Peyron, M Wallon, C Bernardoux
Molecular and Cellular Biochemistry
|
May 10, 1995
Regulation of ornithine decarboxylase during cell growth. Changes in the stability and translatability of the mRNA, and in the turnover of the protein
U M Wallon, L Persson, O Heby
FEBS Letters
|
July 30, 1990
Superinduction of ornithine decarboxylase (ODC) by actinomycin D is due to stimulation of ODC mRNA translation
U M Wallon, L Persson, O Heby
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Treatments for toxoplasmosis in pregnancy
F Peyron, M Wallon, C Liou, et al.
Lancet (London, England)
|
August 20, 1994
Toxoplasmosis in pregnancy
M Wallon, F Gandilhon, F Peyron, et al.
BMJ (Clinical Research Ed.)
|
June 4, 1999
Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy
M Wallon, C Liou, P Garner, et al.
The Journal of Biological Chemistry
|
May 12, 1995
Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen
B Steffensen, U M Wallon, C M Overall
Page
of 7